Multisite phosphorylation of Pin1-associated mitotic phosphoproteins revealed by monoclonal antibodies MPM-2 and CC-3
© Albert et al; licensee BioMed Central Ltd. 2004
Received: 28 October 2003
Accepted: 01 June 2004
Published: 01 June 2004
The peptidyl-prolyl isomerase Pin1 recently revealed itself as a new player in the regulation of protein function by phosphorylation. Pin1 isomerizes the peptide bond of specific phosphorylated serine or threonine residues preceding proline in several proteins involved in various cellular events including mitosis, transcription, differentiation and DNA damage response. Many Pin1 substrates are antigens of the phosphodependent monoclonal antibody MPM-2, which reacts with a subset of proteins phosphorylated at the G2/M transition.
As MPM-2 is not a general marker of mitotic phosphoproteins, and as most mitotic substrates are phosphorylated more than once, we used a different phosphodependent antibody, mAb CC-3, to identify additional mitotic phosphoproteins and eventual Pin1 substrates by combining affinity purification, MALDI-TOF mass spectrometry and immunoblotting. Most CC-3-reactive phosphoproteins appeared to be known or novel MPM-2 antigens and included the RNA-binding protein p54nrb/nmt55, the spliceosomal protein SAP155, the Ki-67 antigen, MAP-1B, DNA topoisomerases II α and β, the elongation factor hSpt5 and the largest subunit of RNA polymerase II. The CC-3 mitotic antigens were also shown to be Pin1 targets. The fine CC-3- and MPM-2-epitope mapping of the RNA polymerase II carboxy-terminal domain confirmed that the epitopes were different and could be generated in vitro by distinct kinases. Finally, the post-mitotic dephosphorylation of both CC-3 and MPM-2 antigens was prevented when cellular Pin1 activity was blocked by the selective inhibitor juglone.
These observations indicate that the mitotic phosphoproteins associated with Pin1 are phosphorylated on multiple sites, suggesting combinatorial regulation of substrate recognition and isomerization.
One of the biggest challenge in cell biology and cancer research is still to understand how cells divide and proceed to the equal partition of their genetic material in each daughter cell. The mechanisms underlying mitosis and cytokinesis are tightly controlled and reversible protein phosphorylation plays a major role in this regulation . Early and late mitotic events are dependent on protein phosphorylation by multiple serine and threonine kinases of the NIMA, Polo and Aurora families at the head of which sits the Cdk1/cyclin B complex [1–5]. The nature of most protein substrates of these kinases is still unknown so that the precise roles they play in the regulation of mitosis and cytokinesis remain to be clarified.
A few monoclonal antibodies (mAbs) have been raised in different laboratories against mitotic cell extracts and shown to react with subsets of proteins that are phosphorylated upon entry into mitosis [6–9]. The most characterized of these antibodies, mAb MPM-2, was selected for its preferential reactivity towards mitotic versus interphase cells  and shown to react with a phospho-epitope present on a set of proteins concentrated in the centrosomes, the kinetochores, the mitotic spindle and the midbody [6, 10], reinforcing the idea that the structural rearrangements observed during mitosis are controlled by phosphorylation events. After twenty years of continuous use as a mitotic marker in scores of laboratories -and insistent efforts to characterize the epitope(s) and the kinases involved- it is now clear that many MPM-2 antigens are important mitotic regulators and effectors. They include the Cdc25 phosphatase , the Cdk1-inhibitory Wee1 and Myt1 kinases [12–14], the NIMA kinase , the microtubule associated-proteins MAP-1 and MAP-4 [16, 17], DNA topoisomerase II α and β , p42mapk , and the Cdc27 component of the anaphase-promoting complex (APC) . Phosphorylation of the MPM-2 antigenic sites is thought to be functionally important as the MPM-2 antibody inhibits oocyte maturation upon microinjection and neutralizes mitosis promoting factor activity from M-phase extracts .
The biological relevance of MPM-2 phosphoepitopes was further reinforced when Shen and coworkers  showed that the peptidyl-prolyl isomerase (PPIase) Pin1 could bind and regulate many mitotic phosphoproteins also recognized by MPM-2. PPIases are ubiquitous enzymes catalyzing the cis-trans isomerization of the peptide bond preceding a proline residue and are thought to be involved in protein folding, protein assembly, protein trafficking or in the direct regulation of protein activity . Pin1 is unique among prolyl isomerases in that it specifically targets proline residues preceded by a phosphoserine (pS-P) or a phosphothreonine (pT-P) [24–26]. Pin1 is a ubiquitously expressed protein that is essential for cell cycle progression in yeast and in mammalian cells . Furthermore, Pin1 has been shown to interact with the essential mitotic kinase NIMA and to suppress its mitosis-promoting activity . It is now believed that Pin1 acts as an essential mitotic regulator since, in addition to NIMA, it binds other MPM-2-reactive proteins with important mitotic functions including Cdc25 [22, 28], Myt1, Wee1, Plk1 and Cdc27 . In the recent years, it was postulated that the analysis of the phosphorylated sites recognized by both Pin1 and MPM-2 might be a good starting point for a better understanding of the general role of phosphorylation in the mitotic processes. These efforts, mainly orchestrated by K.P. Lu and collaborators, have led to the elaboration of a novel post-phosphorylation regulatory mechanism, in which the isomerase Pin1 induces conformational changes into targeted proteins that have been first phosphorylated by proline-directed kinases [29, 30].
The regulative action of Pin1 may not be confined to mitotic processes. Recent results have shown that DNA damage induces an interaction between Pin1 and p53 depending on specific pS-P motifs in p53 [31–33], indicating that phosphorylation-dependent prolyl isomerization is a signalling mechanism also operating in the genotoxic response . Interestingly, it was shown that efficient binding of the p53 protein to Pin1 requires phosphorylation at all three sites of p53 involved in the interaction [32, 33].
Previous work from our laboratory has shown that, in human interphase cells, Pin1 interacts with two transcription-related proteins in a phosphorylation-dependent manner: the hyperphosphorylated form of RNA polymerase II largest subunit Rpb1 , and a phosphorylated form of the transcription elongation factor hSpt5 . Moreover, studies in yeast provided genetic evidence that Ess1, the yeast homolog of Pin1, interacts with the transcription machinery as most genetic suppressors of ess1 mutants encode proteins involved in transcription  consistent with the earlier observation that ess1 mutants are defective in mRNA processing [38, 39]. These results also indicate that Pin1 operates at multiple levels.
The discovery of the association of Pin1 with Rpb1 and hSpt5 was made possible thanks to the availability of a monoclonal antibody (mAb CC-3) selected for its strong phospho-dependent reactivity with mitotic cells and with nuclear speckles of interphase cells . The interphase CC-3 antigens located in the nuclear speckles were identified as Rpb1 and hSpt5 [35, 36] but the numerous CC-3 mitotic antigens have not been identified yet. As CC-3 behavior was somewhat reminescent of that of MPM-2, a comparison of both mAbs initially revealed that they share the hyperphosphorylated form of Rpb1 as their major interphase antigen . However, their epitope on Rpb1 appeared to be different since upon a heat shock, MPM-2 reactivity was increased whereas that of CC-3 was diminished, suggesting that both antibodies may discriminate between distinct functional forms of RNA polymerase II [35, 40].
In the present work, MALDI-TOF mass spectrometry and immunoblotting were combined to identify the major CC-3 mitotic antigens. They included a few proteins involved in transcription and/or mRNA maturation and most of them also appeared to be known or novel MPM-2 antigens. The fine CC-3- and MPM-2-epitope mapping of the carboxy-terminal domain (CTD) of Rpb1 confirmed that the epitopes are different and can be generated in vitro by distinct kinases. Pulldown experiments suggest that the CC-3 mitotic antigens are also Pin1 targets. Finally, incubation of HeLa cells with juglone, an irreversible Pin1 inhibitor , prevented the dephosphorylation of both mitotic MPM-2 and CC-3 epitopes. These observations suggest that Pin1 might promote M phase exit by stimulating the dephosphorylation rate of the mitotic regulators and/or effectors on multiple sites revealed by mAbs CC-3 and MPM-2.
MAb CC-3 is a mitotic marker
CC-3 and MPM-2 are phosphodependent mouse monoclonal antibodies strongly reactive with mitotic cells [6, 7]. In interphase cells, the reactivity of both antibodies is confined to discrete nuclear speckles and has been previously shown to be mainly mediated by phosphoepitopes located on the CTD of Rpb1 . The immunoblot reactivities of CC-3 and MPM-2 on mitotic extracts reveal that their mitotic antigens are much more numerous and the overall patterns are sufficiently distinct to expect that CC-3 and MPM-2 epitopes are different . In addition, the comparison of CC-3 and MPM-2 immunofluorescence reactivities at different stages of the cell cycle reveals subtle differences between otherwise similar patterns. For example, the centrosomes of interphase cells  as well as the midbodies during cytokinesis (data not shown) are labelled more intensely with MPM-2.
Novel CC-3 mitotic antigens identified by MALDI-TOF-MS and ProFound research engine
Identified CC-3 mitotic antigens
Theoretical molecular weight
Number of matched peptides
Min. sequence coverage (%)
Estimated Z score
Ki-67 long form
Ki-67 short form
MAP-1B, isoform 1
Since the CC-3 immunoreactivity in the high Mr region is rather complex , alternative methods to MALDI-TOF mass spectrometry were used to identify other CC-3-antigens. A few candidate proteins in the 170–220 kDa range of SDS gels were already suspected because they had been described as MPM-2 antigens (DNA topoisomerases II α and β) or because they reacted with mAb CC-3 in interphase cells (Rpb1 and hSpt5). Thus, immunoblots using anti-DNA topoisomerase II α and β showed reactive bands in the MPM-2 as well as in the CC-3 mitotic immunoprecipitates. Likewise, Rpb1 and hSpt5 also proved to be mitotic CC-3- and MPM-2-antigens (Fig. 1A). Therefore, it turns out that most of the CC-3 mitotic antigens identified up to now are also MPM-2 reactive: p54nrb/nmt55, Rpb1 and hSpt5 as novel mitotic MPM-2 antigens and MAP-1B, Ki-67 and DNA topoisomerases II as already known MPM-2 antigens. The spliceosomal protein SAP155 is the sole mitotic antigen specifically recognized by CC-3 identified to date. These results prompted us to meticulously compare the nature of the CC-3 and MPM-2 epitopes on a common mitotic and interphase antigen, the CTD of Rpb1.
Fine CC-3 and MPM-2 epitope mapping on the CTD of Rpb1
CC-3 antigens are also targets for the cis/trans peptidyl-prolyl isomerase Pin1
To verify whether the interaction between Pin1 and the CC-3- and MPM-2-reactive mitotic phosphoproteins was direct and driven by the WW domain, immunopurified CC-3 and MPM-2 antigens were subjected to a blot overlay experiment using Pin1 and the WW mutant as probes (Fig. 4C). The specificity of the Pin1 overlay was confirmed by the absence of reactivity of the molecular weight marker bands (Fig. 4C, lane M). In addition, a more robust and complex reactivity was noticed, as expected, on a mitotic extract compared to an interphase extract when equivalent protein amounts were loaded (Fig. 4C, lanes 1 and 2). The strong binding of Pin1 to mitotic CC-3 and MPM-2 immunoprecipitated antigens suggests that Pin1 association with these phosphoproteins is direct (Fig. 4C, lanes 5 and 6). Both CC-3 and MPM-2 interphase immunoprecipitates (lanes 3 and 4) were also processed and the result confirmed that Rpb1 and at least one other interphase protein, most probably hSpt5, interact directly with Pin1 (Fig. 1 and ). The WW mutant W34A showed a marked reduction of binding in the blot overlay experiment (Fig. 4C, middle panel), supporting the view that CC-3 mitotic antigens are, like MPM-2 antigens, direct targets of Pin1 and that this interaction is driven by the WW domain. Finally, it has to be noticed that the SAP155 protein, which appeared to be a CC-3-positive and a MPM-2-negative antigen (Fig. 1A) was pulled down by Pin1 as revealed by Western blot (Fig. 4D), suggesting that the MPM-2-immunoreactivity may not be a prerequisite for Pin1 binding. In addition, DNA topoisomerase II α, shown to be a common antigen to both antibodies (Fig. 1), was also specifically pulled down by Pin1 (Fig. 4D).
CC-3 and MPM-2 antigens are not dephosphorylated after mitosis in the presence of juglone, a Pin1 specific inhibitor
Many observations strongly support the idea that mAb CC-3 reacts with a phosphodependent epitope different from that recognized by MPM-2. First, in immunofluorescence studies of HeLa cells, MPM-2 labelled additional structures when compared to CC-3. Second, the Western blot patterns of both antibodies showed major differences . Third, some proteins may react exclusively with either CC-3 or MPM-2 as illustrated by the CC-3-exclusive SAP155 antigen. Fourth, a heat shock treatment of HeLa cells increased MPM-2 immunoreactivity of Rpb1 whereas that of CC-3 was decreased [35, 40]. Finally, the experiments using the CTD recombinant fragments and peptides of Rpb1 showed that MPM-2 and CC-3 epitopes can be differentially generated in vitro by distinct kinases. Altogether, these observations indicate that the CC-3 and MPM-2 phosphoepitopes are different and that a single mitotic phosphoprotein may be phosphorylated on several sites by different kinases, suggesting a combinatorial regulation of the mitotic events. Multisite phosphorylation of proteins is a common mechanism to increase the regulatory potential of proteins  and was envisaged a few years ago for the regulation of cell division by Stukenberg and coworkers  after they have systematically undertaken the identification of mitotic phosphoproteins using a screening procedure based on either electrophoretic mobility shifts or MPM-2-epitope recognition. Their study revealed that MPM-2 recognition was not a hallmark of all mitotic phosphoproteins and that no common motifs existed among the substrates that are phosphorylated during mitosis. On the other hand, most of the proteins they have identified contained several S-P or T-P groupings and displayed multiple phosphorylated forms . This observation could explain the variety of immunoreactivities noticed with both CC-3 and MPM-2 and the association of their antigens with Pin1 as seen in the overlay experiments. More recently, Stukenberg and Kirschner  found that a Pin1-catalyzed conformational change -monitored among other assays by MPM-2 differential reactivity- was located in such a "SP-rich" region on Cdc25. Whether Pin1 catalyzes similar conformational changes on other mitotic (or interphase) substrates remain to be demonstrated but mAb CC-3 certainly constitutes an additional probe to reach this objective.
A striking feature of the major CC-3 antigens identified in our study is that many of them localize to the nucleus in interphase cells and are associated with transcriptional and/or pre-mRNA processing events. This finding is consistent with one conclusion of Stukenberg and coworkers  that is, a large percentage of the proteins phosphorylated during mitosis are transcriptional and translational regulators. Recently, the splicing factor SAP155 was shown to be highly phosphorylated in mitotically arrested COS-1 cells and HeLa cells compared to asynchronous cells . The phosphorylated sites lie in a TP-rich domain that mediates binding to NIPP1, a splicing factor that functions also as a PP1 phosphatase regulator. The use of the Cdk inhibitor roscovitine and the in vitro phosphorylation of SAP155 with Cdk1 strongly support the idea that Cdk1/cyclin B is the major SAP155 mitotic kinase. The relevance of NIPP1-SAP155 interaction may contribute to the mitotic silencing of splicing . These results support the present finding that SAP155 is mitotically phosphorylated in mitosis on the mAb CC-3-epitope and that Cdk1 could be the major CC-3 mitotic kinase (see below). Among the CC-3-reactive proteins that we have identified, the splicing and transcription-associated protein p54nrb/nmt55 and the human transcription elongation factor hSpt5 appeared to be novel MPM-2 antigens. The former possibly corresponds to a previously described MPM-2-reactive p55 protein shown to be threonine phosphorylated upon entry in mitosis . The p54nrb/nmt55 protein contains one putative Cdk1 consensus site (QNHT PRK) in its most N-terminal part and several T-P pairs in a proline-rich domain in its carboxy terminus . This protein contains two RNA recognition motifs within a 320-aa stretch also found in the splicing factor PSF. Its expression was shown to be down regulated in a subset of breast tumors . The mouse homolog of p54nrb/nmt55, NonO, was independently isolated as a DNA binding transcription factor , able to enhance the association of many DNA-binding proteins to their targets . Interestingly, the p54nrb/nmt55 and PSF proteins of HeLa cells have recently been shown to specifically bind the CTD of Rpb1 and it has been suggested that these proteins could provide a direct link between transcription and pre-mRNA processing . This property could be the cause of the purification of p54nrb/nmt55 by CC-3-affinity since the CTD, as shown on figure 1, contains several CC-3 epitopes. However, we think that p54nrb/nmt55 is a bona fide CC-3 antigen and that it did not merely co-purify as a Rpb1 partner because it was shown to be CC-3-reactive in Western blots when immunoprecipitated from mitotic extracts with the anti-p54nrb/nmt55 antibody. In addition, we have recently been able to generate the CC-3-epitope on a recombinant p54nrb/nmt55 protein in vitro using ATP and a mitotic extract as a source of kinases (Proteau A., unpublished results).
The repetitive nature of the CTD, which harbors an impressive series of phosphorylable S-P or T-P pairs, makes Rpb1 one of the more complex CC-3 and MPM-2 antigens. The results described in figure 2 revealed a stronger CC-3 affinity for the GST-CTDs phosphorylated by a mitotic extract than by Cdk9/cyclinT1, as opposed to MPM-2 reactivity. Maybe most importantly, the generation of the CC-3 epitope by the mitotic extract was stronger on the C-CTD, which possesses only three consensus YSPTSPS repeats. As starfish Cdk1 kinase could generate a strong CC-3 signal on the C-teminal part of the CTD in vitro , this observation could mean that Cdk1 is the major kinase of our mitotic extract involved in phosphorylation of the CC-3 epitope. This segment of the CTD contains mostly heptads diverging from the consensus at position 7 and it was shown by Zhang and Corden  that the best susbtrate for Cdk1 was a CTD peptide with a lysine at this position (YSPTSPK). It has previously been shown that TFIIH also increased CC-3 immunoreactivity at the C-terminal half of the CTD in vitro  and Cdk7, a component of TFIIH, preferentially phosphorylates synthetic heptapeptides containing a lysine at position 7 . Altogether, these observations suggest that the CC-3 epitope can be generated by a phosphorylated serine at position 2 of the consensus repeat, as demonstrated by the ELISA reactivity of the (YSPTSPS)4 peptides and in a previous study , but the affinity of the antibody is most probably enhanced by the natural context of the non canonical repeats of the C-CTD and presumably, by a similarly permissive environment in the mitotic antigens. In line with this suggestion, it has to be noticed that mAb H5, also directed to Serine-2 of the CTD , revealed a single reactive band corresponding to Rpb1 when blotted on mitotic cell extracts (not shown). Therefore, in spite of the identical specificity of H5 and CC-3 towards the Serine-2 of the CTD, CC-3 clearly recognizes a different motif surrounding the pS-P bond since it reacts with many more mitotic phosphoproteins.
The Cdk9-induced MPM-2 epitope appeared stronger in the highly conserved N-terminal part of the CTD in agreement with a previous report showing that the Cdk9 kinase complex preferentially phosphorylates this portion of the CTD . In addition to demonstrating the different nature of both epitopes, these observations support the view that whichever kinases are involved, MPM-2 and CC-3 could react with functionally distinct isoforms of hyperphosphorylated Rpb1. Remarkably, the loss of the CC-3 epitope and the concurrent increase of MPM-2 reactivity noticed after a heat shock [35, 40], could mean that the bulk of phosphorylated serine residues shift from the C-terminal half of the CTD to the N-terminal part under these conditions. Work is under progress to verify if the stress-induced hyperphosphorylation of the CTD contributes to the appearance of the MPM-2 epitope. It has to be kept in mind that such a net increase in the phosphorylation level of Rpb1 could result from the stress-induced activation of kinases  and/or inactivation of a CTD phosphatase . According to the ELISA results showing a stronger MPM-2 and a weaker CC-3 reactivity when the CTD peptides are phosphorylated on both serines 2 and 5, it could also be that the heat shock treatment increases the phosphorylation level of Rpb1 on both serines 2 and 5, providing an alternative explanation to the fact that MPM-2 immunoreactivity is increased by this treatment and that of CC-3 is decreased. Whether the heat shock-induced alterations of the CTD phosphorylation contribute to the modifications of gene expression characteristic of the heat shock response remains to be explored.
As CC-3 and MPM-2 antigens were shown to be targets of the peptidyl-prolyl isomerase Pin1, it was of interest to examine their dephosphorylation at the exit of mitosis. It has indeed been shown that Pin1 can alter the dephosphorylation rate of some of its binding partners [63–65]. When nocodazole-arrested mitotic cells were chased into G1 in the presence of juglone, a Pin1 inhibitor , we observed that most CC-3 and MPM-2 antigens remained in the phosphorylation state contrary to the situation in juglone-free medium. In addition, the cells treated with the inhibitor remained rounded and did not attach to the culture dish. Because juglone potentially interacts at other levels , these results should be interpreted with caution, but they are consistent with the recent suggestion that Pin1 could regulate the activity of phosphoproteins distributed at different mitotic structures by controlling the accessibility of pS/pT-P motifs to phosphatases . Further experiments using more specific Pin1 inhibitors such as those recently discovered by Uchida and collaborators  will help to resolve this issue.
We provided evidence that another monoclonal antibody, CC-3, recognizes a different epitope borne by a subset of mitotic phosphoproteins which, for the most part, are also MPM-2 antigens and Pin1-reactive, suggesting the existence of a combinatorial regulative mechanism. The availability of different phosphorylation-state-specific antibodies to mitotic antigens may thus be crucial to elucidate the functional impact of multisite phosphorylation of regulators and effectors on cell division.
Cell cultures and synchronization
HeLa cells (American Type Culture Collection) were cultured in Iscove's Modified Dulbecco's Medium (Gibco) supplemented with 10% FBS (Medicorp) at 37°C in 5% CO2. Mitotic HeLa cells were obtained by incubating the cells with nocodazole (Sigma-Aldrich) at a final concentration of 0.08 μg/ml for 16 hours. In some experiments, mitotic HeLa cells were harvested, washed twice with PBS and incubated in medium supplemented or not with juglone (Sigma-Aldrich) for 5 hours at 37°C. Stock solutions of juglone were freshly prepared in 0.1N NaOH and used at a final concentration of 10 or 20 μg/ml.
MAb CC-3 (IgG2a) was obtained after immunization of a Balb/C mouse with pharyngeal regions isolated from 72-hour chick embryos in a search for developmental markers [7, 69]. The mouse monoclonal antibody MPM-2 (IgG1) was purchased from Upstate Biotechnology. MAb POL3/3 (IgG1) recognizes Rpb1 in a conserved region located outside the CTD and was kindly provided by E. K. F. Bautz . NMT-5 (rabbit polyclonal antibody) and mouse monoclonal NMT-1 were raised against the splicing cofactor p54nrb/nmt55 and were kindly provided by A. M. Traish . The anti-SAP155 is a rabbit polyclonal antibody kindly provided by R. Reed . The anti-hSpt5 monoclonal rat antibody raised against a C-terminal fragment of the human Spt5 protein was a gift from H. Handa . The anti-DNA topoisomerase II α (8D2) and anti-DNA topoisomerase II β (5A7) were kindly provided by M. Tanaka . The anti-Pin1 polyclonal antibody was raised by immunizing a rabbit with purified full-lenght His-tagged recombinant Pin1 protein .
Sample preparation and immunoprecipitation
For whole cell extracts, interphase and mitotic HeLa cells were directly solubilized in sample buffer (63 mM Tris pH 6.8, 2.3% SDS, 5% β-mercaptoethanol, 10% glycerol) and boiled for 6 minutes. For immunoprecipitation, mitotic or interphase cells were homogenized at 4°C in IP buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, 0.2% NaF, 0.8% SDS, 1 mM EDTA, 1X protease inhibitor cocktail (Roche Diagnostics) and 40 nM microcystin). The lysates were sheared with a 25G needle several times and boiled for 5 minutes. To neutralize the SDS and to allow antigen-antibody interactions, one volume of Triton buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, 0.2% NaF, 4% Triton X-100, 1 mM EDTA, 1X protease inhibitor cocktail and 40 nM microcystin) was added to the lysates and cleared by centrifugation at 16000 g for 5 minutes. Lysates were incubated for 90 minutes at room temperature with the primary antibodies first coated on goat anti-mouse IgG (whole molecule)-agarose (Sigma-Aldrich). The beads were washed in the same buffer followed by antigen solubilization in electrophoresis sample buffer.
Samples were resolved by 7% or 10% SDS-PAGE gels and transfered to nitrocellulose membranes. The blots were blocked with 1% blocking reagent (Roche Diagnostics) diluted in Tris-buffered saline (TBS-T) (10 mM Tris pH 7.65, 150 NaCl and 0.05% Tween-20) for 60 minutes at 37°C and probed overnight with the primary antibodies at 4°C. Peroxydase-conjugated anti-mouse or anti-rabbit secondary antibodies (Jackson ImmunoResearch Laboratories) were used for chemiluminescence detection (Roche Diagnostics). The molecular mass markers used were: myosin heavy chain (205 kDa), β-galactosidase (116 kDa), phosphorylase b (97 kDa), bovine serum albumin (66 kDa), ovalbumin (45 kDa) and carbonic anhydrase (29 kDa).
The purification of CC-3 mitotic antigens was carried out by immunoprecipitation of mitotic cell extracts solubilized in the IP buffer as described above. The purified antigens were separated on a 9% SDS-PAGE gel, Coomassie blue stained and relatively enriched protein bands were excised and subjected to in-gel trypsin digestion as described . Mass spectrometry analysis and protein purification were performed at the Centre de protéomique de l'est du Québec (Dr G. G. Poirier, dir.). An aliquot (1 μl) of the peptide extract was mixed with 1 μl saturated solution of α-cyano-4-hydroxycinnamic acid matrix (10 mg/ml) prepared in TFA (Trifluoroacetic acid 0.1%, Acetonitrile 50%) and submitted to MALDI-TOF mass spectrometry using a Voyager DE PRO mass spectrometer (Applied Biosystems). Molecular masses of the tryptic peptide profiles were used to search by peptide fingerprinting the National Center for Biotechnology Information (NCBI) database using the ProFound software (ProteoMetrix). Defined search parameters were as follows: monoisotopic mass tolerance 0.20 Da, 1 missed cut allowed, cystein as S-carbamidomethyl-derivative and oxidation of methionine allowed. The reported results were selected on the basis of restriction to species Homo sapiens.
In vitro phosphorylation
The Cdk9/cyclin T1 complex has been kindly provided by Dr O. Bensaude and was prepared from baculovirus-infected Sf9 cells as described . For the mitotic extract, nocodazole-treated cells were prepared as above and homogenized in 3–5 pellet volumes of extraction buffer (50 mM Tris pH 7.4, 250 mM NaCl, 1 mM EDTA, 50 nM NaF, 1 mM DTT, 0.1% Triton X-100, 1X protease inhibitor cocktail and 40 nM microcystin). The lysate was solubilized with a 25G needle and spun for 30 minutes at 16 000 g. The GST-N-CTD and the GST-C-CTD fusion proteins were produced from a pGEX-3X (Pharmacia) construction kindly provided by Dr M. Vigneron  and purified on glutathione-Sepharose (Sigma-Aldrich). The GST-CTD recombinant proteins were phosphorylated in vitro with the mitotic extract for 60 minutes at 30°C in a final assay volume of 25 μl containing 50 mM Tris pH 7.5, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT, 40 mM β-glycerophosphate, 20 mM ρ-nitrophenylphosphate, 0.1 mM sodium vanadate, 20 nM microcystin, 0.7 mM ATP, 5 μl of mitotic extract and 0.2 μg of N-CTD or C-CTD. Alternatively, the constructs were phosphorylated by Cdk9/cyclin T1 in glycerophosphate buffer (20 mM sodium glycerophosphate pH 7.3, 5 mM MgCl2, 1 mM EDTA, 1 mM DTT, 10% glycerol) with 1 mM ATP for 60 minutes at 30°C. The phosphorylated peptides were purified on glutathione Sepharose resin, eluted with sample buffer and subjected to SDS-PAGE.
CC-3 and MPM-2 reactivity of synthesized CTD peptides
For analysis of CC-3 and MPM-2 reactivity of the CTD, biotinylated CTD peptides containing four consensus repeats (YSPTSPS) phosphorylated in all repeats at the indicated serines were used (a kind gift of Dr S. Buratowski ). Peptides were coupled to streptavidin-coated 96-well plates (Pierce) and processed for ELISA according to the instructions of the manufacturer except that TBS-T was used as the washing buffer and that 1% blocking reagent (Roche Diagnostics) in TBT-T was used to block the plate and to dilute the CC-3 and MPM-2 antibodies. Peroxydase-conjugated anti-mouse IgG secondary antibody (Jackson ImmunoResearch Laboratories) was used at 1/1000. The colorimetric reaction was developed using ABTS tablets (Roche Diagnostics) and the resulting absorbances were recorded at 405 nm with a Vmax kinetic microplated reader from Molecular Devices.
Pin1 pulldown experiments
His-tagged Pin1 recombinant protein was cloned and purified as described . His-tagged Pin1 mutants W34A and C113A were kindly provided by Dr O. Bensaude. Equivalent amounts of wild-type and mutant Pin1 proteins and of an irrelevant his-tagged protein (Pbp5) used as a control were loaded onto distinct histidine-binding columns (Novagen) and incubated for 1 hour at 4°C with mitotic HeLa cell lysates prepared in fresh CHAPS buffer (25 mM Tris pH 7.5, 150 mM NaCl, 0.5% CHAPS, 0.2% NaF, 2X protease inhibitor cocktail without EDTA and 40 nM microcystin) and clarified at 16 000 g for 30 minutes at 4°C. The resins were then washed three times with CHAPS buffer containing increasing imidazole concentrations (10 mM, 35 mM and 60 mM). Bound fractions were eluted with sample buffer 2X and heated for 5 minutes at 95°C. Volumes corresponding to the same cellular equivalents were subjected to Western blots.
Pin1 blot overlay
Different samples were separated on a 10% SDS-PAGE gel and transfered on nitrocellulose. The membrane-bound proteins were renatured overnight at 4°C in Blotto (5% lyophilized skim milk dissolved in PBS (pH 7.1) containing 0.2% Tween-20, 1 mM DTT and 1 mM PMSF) and incubated for 2 hours at the same temperature with 1.3 μg/ml of wild-type or W34A mutant Pin1 proteins. The membranes were washed 3 × 15 minutes in Blotto without DTT and PMSF, incubated with the anti-Pin1 antibody (1/10 000 dilution) for 1 hour at room temperature and processed for chemiluminescence as described above.
We want to thank Drs Olivier Bensaude and Marie-Françoise Dubois for providing the constructs of the Pin1 mutants. We also thank Dr Minkyu Kim and Dr Stephen Buratowski for the kind gift of the biotinylated CTD phosphopeptides. This research was supported by the Natural Sciences and Engineering Research Council of Canada (Grant 122625-01 to M.V. and studentships to A.L.A. and S.B.L.).
- Nigg EA: Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol. 2001, 2: 21-32. 10.1038/35048096.View ArticlePubMedGoogle Scholar
- Fry AM, Nigg EA: Cell cycle. The NIMA kinase joins forces with Cdc2. Curr Biol. 1995, 5: 1122-1125.View ArticlePubMedGoogle Scholar
- Lane HA, Nigg EA: Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes. J Cell Biol. 1996, 135: 1701-1713. 10.1083/jcb.135.6.1701.View ArticlePubMedGoogle Scholar
- Schultz SJ, Fry AM, Sutterlin C, Ried T, Nigg EA: Cell cycle-dependent expression of Nek2, a novel human protein kinase related to the NIMA mitotic regulator of Aspergillus nidulans. Cell Growth Differ. 1994, 5: 625-635.PubMedGoogle Scholar
- Glover DM, Leibowitz MH, McLean DA, Parry H: Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. Cell. 1995, 81: 95-105.View ArticlePubMedGoogle Scholar
- Davis FM, Tsao TY, Fowler SK, Rao PN: Monoclonal antibodies to mitotic cells. Proc Natl Acad Sci U S A. 1983, 80: 2926-2930.PubMed CentralView ArticlePubMedGoogle Scholar
- Thibodeau A, Vincent M: Monoclonal antibody CC-3 recognizes phosphoproteins in interphase and mitotic cells. Exp Cell Res. 1991, 195: 145-153.View ArticlePubMedGoogle Scholar
- Kuriyama R, Nislow C: Molecular components of the mitotic spindle. Bioessays. 1992, 14: 81-88.View ArticlePubMedGoogle Scholar
- Butschak G, Harborth J, Osborn M, Karsten U: New monoclonal antibodies recognizing phosphorylated proteins in mitotic cells. Acta Histochem. 1995, 97: 19-31.View ArticlePubMedGoogle Scholar
- Vandre DD, Davis FM, Rao PN, Borisy GG: Phosphoproteins are components of mitotic microtubule organizing centers. Proc Natl Acad Sci U S A. 1984, 81: 4439-4443.PubMed CentralView ArticlePubMedGoogle Scholar
- Kuang J, Ashorn CL, Gonzalez-Kuyvenhoven M, Penkala JE: cdc25 is one of the MPM-2 antigens involved in the activation of maturation-promoting factor. Mol Biol Cell. 1994, 5: 135-145.PubMed CentralView ArticlePubMedGoogle Scholar
- Mueller PR, Coleman TR, Dunphy WG: Cell cycle regulation of a Xenopus Wee1-like kinase. Mol Biol Cell. 1995, 6: 119-134.PubMed CentralView ArticlePubMedGoogle Scholar
- Mueller PR, Coleman TR, Kumagai A, Dunphy WG: Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science. 1995, 270: 86-90.View ArticlePubMedGoogle Scholar
- Wells NJ, Watanabe N, Tokusumi T, Jiang W, Verdecia MA, Hunter T: The C-terminal domain of the Cdc2 inhibitory kinase Myt1 interacts with Cdc2 complexes and is required for inhibition of G(2)/M progression. J Cell Sci. 1999, 112: 3361-3371.PubMedGoogle Scholar
- Ye XS, Xu G, Pu RT, Fincher RR, McGuire SL, Osmani AH, Osmani SA: The NIMA protein kinase is hyperphosphorylated and activated downstream of p34cdc2/cyclin B: coordination of two mitosis promoting kinases. Embo J. 1995, 14: 986-994.PubMed CentralPubMedGoogle Scholar
- Vandre DD, Centonze VE, Peloquin J, Tombes RM, Borisy GG: Proteins of the mammalian mitotic spindle: phosphorylation/dephosphorylation of MAP-4 during mitosis. J Cell Sci. 1991, 98 ( Pt 4): 577-588.Google Scholar
- Vandre DD, Davis FM, Rao PN, Borisy GG: Distribution of cytoskeletal proteins sharing a conserved phosphorylated epitope. Eur J Cell Biol. 1986, 41: 72-81.PubMedGoogle Scholar
- Taagepera S, Rao PN, Drake FH, Gorbsky GJ: DNA topoisomerase II alpha is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2. Proc Natl Acad Sci U S A. 1993, 90: 8407-8411.PubMed CentralView ArticlePubMedGoogle Scholar
- Taagepera S, Dent P, Her JH, Sturgill TW, Gorbsky GJ: The MPM-2 antibody inhibits mitogen-activated protein kinase activity by binding to an epitope containing phosphothreonine-183. Mol Biol Cell. 1994, 5: 1243-1251.PubMed CentralView ArticlePubMedGoogle Scholar
- King RW, Peters JM, Tugendreich S, Rolfe M, Hieter P, Kirschner MW: A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell. 1995, 81: 279-288.View ArticlePubMedGoogle Scholar
- Kuang J, Zhao J, Wright DA, Saunders GF, Rao PN: Mitosis-specific monoclonal antibody MPM-2 inhibits Xenopus oocyte maturation and depletes maturation-promoting activity. Proc Natl Acad Sci U S A. 1989, 86: 4982-4986.PubMed CentralView ArticlePubMedGoogle Scholar
- Shen M, Stukenberg PT, Kirschner MW, Lu KP: The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev. 1998, 12: 706-720.PubMed CentralView ArticlePubMedGoogle Scholar
- Schmid FX: Prolyl isomerase: enzymatic catalysis of slow protein-folding reactions. Annu Rev Biophys Biomol Struct. 1993, 22: 123-142. 10.1146/annurev.bb.22.060193.001011.View ArticlePubMedGoogle Scholar
- Lu PJ, Zhou XZ, Shen M, Lu KP: Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science. 1999, 283: 1325-1328. 10.1126/science.283.5406.1325.View ArticlePubMedGoogle Scholar
- Verdecia MA, Bowman ME, Lu KP, Hunter T, Noel JP: Structural basis for phosphoserine-proline recognition by group IV WW domains. Nat Struct Biol. 2000, 7: 639-43. taf/DynaPage.taf?file=/nsb/journal/v7/n8/full/nsb0800_639.html taf/DynaPage.taf?file=/nsb/journal/v7/n8/abs/nsb0800_639.html. 10.1038/77929.View ArticlePubMedGoogle Scholar
- Yaffe MB, Schutkowski M, Shen M, Zhou XZ, Stukenberg PT, Rahfeld JU, Xu J, Kuang J, Kirschner MW, Fischer G, Cantley LC, Lu KP: Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science. 1997, 278: 1957-1960. 10.1126/science.278.5345.1957.View ArticlePubMedGoogle Scholar
- Lu KP, Hanes SD, Hunter T: A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature. 1996, 380: 544-547. 10.1038/380544a0.View ArticlePubMedGoogle Scholar
- Crenshaw DG, Yang J, Means AR, Kornbluth S: The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1. Embo J. 1998, 17: 1315-1327. 10.1093/emboj/17.5.1315.PubMed CentralView ArticlePubMedGoogle Scholar
- Lu PJ, Zhou XZ, Liou YC, Noel JP, Lu KP: Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J Biol Chem. 2002, 277: 2381-2384. 10.1074/jbc.C100228200.View ArticlePubMedGoogle Scholar
- Zhou XZ, Lu PJ, Wulf G, Lu KP: Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism. Cell Mol Life Sci. 1999, 56: 788-806. 10.1007/s000180050026.View ArticlePubMedGoogle Scholar
- Wulf GM, Liou YC, Ryo A, Lee SW, Lu KP: Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J Biol Chem. 2002, 277: 47976-47979. 10.1074/jbc.C200538200.View ArticlePubMedGoogle Scholar
- Zacchi P, Gostissa M, Uchida T, Salvagno C, Avolio F, Volinia S, Ronai Z, Blandino G, Schneider C, Del Sal G: The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature. 2002, 419: 853-857. 10.1038/nature01120.View ArticlePubMedGoogle Scholar
- Zheng H, You H, Zhou XZ, Murray SA, Uchida T, Wulf G, Gu L, Tang X, Lu KP, Xiao ZX: The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature. 2002, 419: 849-853. 10.1038/nature01116.View ArticlePubMedGoogle Scholar
- Ryo A, Liou YC, Lu KP, Wulf G: Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer. J Cell Sci. 2003, 116: 773-783. 10.1242/jcs.00276.View ArticlePubMedGoogle Scholar
- Albert A, Lavoie S, Vincent M: A hyperphosphorylated form of RNA polymerase II is the major interphase antigen of the phosphoprotein antibody MPM-2 and interacts with the peptidyl-prolyl isomerase Pin1. J Cell Sci. 1999, 112 ( Pt 15): 2493-2500.Google Scholar
- Lavoie SB, Albert AL, Handa H, Vincent M, Bensaude O: The peptidyl-prolyl isomerase Pin1 interacts with hSpt5 phosphorylated by Cdk9. J Mol Biol. 2001, 312: 675-685. 10.1006/jmbi.2001.4991.View ArticlePubMedGoogle Scholar
- Wu X, Wilcox CB, Devasahayam G, Hackett RL, Arevalo-Rodriguez M, Cardenas ME, Heitman J, Hanes SD: The Ess1 prolyl isomerase is linked to chromatin remodeling complexes and the general transcription machinery. Embo J. 2000, 19: 3727-3738. 10.1093/emboj/19.14.3727.PubMed CentralView ArticlePubMedGoogle Scholar
- Hani J, Schelbert B, Bernhardt A, Domdey H, Fischer G, Wiebauer K, Rahfeld JU: Mutations in a peptidylprolyl-cis/trans-isomerase gene lead to a defect in 3'-end formation of a pre-mRNA in Saccharomyces cerevisiae. J Biol Chem. 1999, 274: 108-116. 10.1074/jbc.274.1.108.View ArticlePubMedGoogle Scholar
- Hani J, Stumpf G, Domdey H: PTF1 encodes an essential protein in Saccharomyces cerevisiae, which shows strong homology with a new putative family of PPIases. FEBS Lett. 1995, 365: 198-202. 10.1016/0014-5793(95)00471-K.View ArticlePubMedGoogle Scholar
- Lavoie SB, Albert AL, Thibodeau A, Vincent M: Heat shock-induced alterations in phosphorylation of the largest subunit of RNA polymerase II as revealed by monoclonal antibodies CC-3 and MPM-2. Biochem Cell Biol. 1999, 77: 367-374. 10.1139/bcb-77-4-367.View ArticlePubMedGoogle Scholar
- Hennig L, Christner C, Kipping M, Schelbert B, Rucknagel KP, Grabley S, Kullertz G, Fischer G: Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry. 1998, 37: 5953-5960. 10.1021/bi973162p.View ArticlePubMedGoogle Scholar
- Pavao M, Huang YH, Hafer LJ, Moreland RB, Traish AM: Immunodetection of nmt55/p54nrb isoforms in human breast cancer. BMC Cancer. 2001, 1: 15-10.1186/1471-2407-1-15.PubMed CentralView ArticlePubMedGoogle Scholar
- Wang C, Chua K, Seghezzi W, Lees E, Gozani O, Reed R: Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis. Genes Dev. 1998, 12: 1409-1414.PubMed CentralView ArticlePubMedGoogle Scholar
- Emili A, Shales M, McCracken S, Xie W, Tucker PW, Kobayashi R, Blencowe BJ, Ingles CJ: Splicing and transcription-associated proteins PSF and p54nrb/nonO bind to the RNA polymerase II CTD. Rna. 2002, 8: 1102-1111. 10.1017/S1355838202025037.PubMed CentralView ArticlePubMedGoogle Scholar
- Dubois MF, Vincent M, Vigneron M, Adamczewski J, Egly JM, Bensaude O: Heat-shock inactivation of the TFIIH-associated kinase and change in the phosphorylation sites on the C-terminal domain of RNA polymerase II. Nucleic Acids Res. 1997, 25: 694-700. 10.1093/nar/25.4.694.PubMed CentralView ArticlePubMedGoogle Scholar
- Bensaude O, Bonnet F, Casse C, Dubois MF, Nguyen VT, Palancade B: Regulated phosphorylation of the RNA polymerase II C-terminal domain (CTD). Biochem Cell Biol. 1999, 77: 249-255. 10.1139/bcb-77-4-249.View ArticlePubMedGoogle Scholar
- Komarnitsky P, Cho EJ, Buratowski S: Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev. 2000, 14: 2452-2460. 10.1101/gad.824700.PubMed CentralView ArticlePubMedGoogle Scholar
- West ML, Corden JL: Construction and analysis of yeast RNA polymerase II CTD deletion and substitution mutations. Genetics. 1995, 140: 1223-1233.PubMed CentralPubMedGoogle Scholar
- Patturajan M, Schulte RJ, Sefton BM, Berezney R, Vincent M, Bensaude O, Warren SL, Corden JL: Growth-related changes in phosphorylation of yeast RNA polymerase II. J Biol Chem. 1998, 273: 4689-4694. 10.1074/jbc.273.8.4689.View ArticlePubMedGoogle Scholar
- Dong B, Horowitz DS, Kobayashi R, Krainer AR: Purification and cDNA cloning of HeLa cell p54nrb, a nuclear protein with two RNA recognition motifs and extensive homology to human splicing factor PSF and Drosophila NONA/BJ6. Nucleic Acids Res. 1993, 21: 4085-4092.PubMed CentralView ArticlePubMedGoogle Scholar
- Cohen P: The regulation of protein function by multisite phosphorylation--a 25 year update. Trends Biochem Sci. 2000, 25: 596-601. 10.1016/S0968-0004(00)01712-6.View ArticlePubMedGoogle Scholar
- Stukenberg PT, Lustig KD, McGarry TJ, King RW, Kuang J, Kirschner MW: Systematic identification of mitotic phosphoproteins. Curr Biol. 1997, 7: 338-348. 10.1016/S0960-9822(06)00157-6.View ArticlePubMedGoogle Scholar
- Stukenberg PT, Kirschner MW: Pin1 acts catalytically to promote a conformational change in Cdc25. Mol Cell. 2001, 7: 1071-1083. 10.1016/S1097-2765(01)00245-3.View ArticlePubMedGoogle Scholar
- Boudrez A, Beullens M, Waelkens E, Stalmans W, Bollen M: Phosphorylation-dependent interaction between the splicing factors SAP155 and NIPP1. J Biol Chem. 2002, 277: 31834-31841. 10.1074/jbc.M204427200.View ArticlePubMedGoogle Scholar
- Zhao JY, Kuang J, Adlakha RC, Rao PN: Threonine phosphorylation is associated with mitosis in HeLa cells. FEBS Lett. 1989, 249: 389-395. 10.1016/0014-5793(89)80665-9.View ArticlePubMedGoogle Scholar
- Basu A, Dong B, Krainer AR, Howe CC: The intracisternal A-particle proximal enhancer-binding protein activates transcription and is identical to the RNA- and DNA-binding protein p54nrb/NonO. Mol Cell Biol. 1997, 17: 677-686.PubMed CentralView ArticlePubMedGoogle Scholar
- Yang YS, Yang MC, Tucker PW, Capra JD: NonO enhances the association of many DNA-binding proteins to their targets. Nucleic Acids Res. 1997, 25: 2284-2292. 10.1093/nar/25.12.2284.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhang J, Corden JL: Identification of phosphorylation sites in the repetitive carboxyl- terminal domain of the mouse RNA polymerase II largest subunit. J Biol Chem. 1991, 266: 2290-2296.PubMedGoogle Scholar
- Rickert P, Corden JL, Lees E: Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases. Oncogene. 1999, 18: 1093-1102. 10.1038/sj.onc.1202399.View ArticlePubMedGoogle Scholar
- Ramanathan Y, Rajpara SM, Reza SM, Lees E, Shuman S, Mathews MB, Pe'ery T: Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences. J Biol Chem. 2001, 276: 10913-10920. 10.1074/jbc.M010975200.View ArticlePubMedGoogle Scholar
- Venetianer A, Dubois MF, Nguyen VT, Bellier S, Seo SJ, Bensaude O: Phosphorylation state of the RNA polymerase II C-terminal domain (CTD) in heat-shocked cells. Possible involvement of the stress-activated mitogen-activated protein (MAP) kinases. Eur J Biochem. 1995, 233: 83-92.View ArticlePubMedGoogle Scholar
- Dubois MF, Marshall NF, Nguyen VT, Dahmus GK, Bonnet F, Dahmus ME, Bensaude O: Heat shock of HeLa cells inactivates a nuclear protein phosphatase specific for dephosphorylation of the C-terminal domain of RNA polymerase II. Nucleic Acids Res. 1999, 27: 1338-1344. 10.1093/nar/27.5.1338.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhou XZ, Kops O, Werner A, Lu PJ, Shen M, Stoller G, Kullertz G, Stark M, Fischer G, Lu KP: Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol Cell. 2000, 6: 873-883. 10.1016/S1097-2765(00)00085-X.View ArticlePubMedGoogle Scholar
- Liu W, Youn HD, Zhou XZ, Lu KP, Liu JO: Binding and regulation of the transcription factor NFAT by the peptidyl prolyl cis-trans isomerase Pin1. FEBS Lett. 2001, 496: 105-108. 10.1016/S0014-5793(01)02411-5.View ArticlePubMedGoogle Scholar
- He J, Lau AG, Yaffe MB, Hall RA: Phosphorylation and cell cycle-dependent regulation of Na+/H+ exchanger regulatory factor-1 by Cdc2 kinase. J Biol Chem. 2001, 276: 41559-41565. 10.1074/jbc.M106859200.View ArticlePubMedGoogle Scholar
- Chao SH, Greenleaf AL, Price DH: Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription. Nucleic Acids Res. 2001, 29: 767-773. 10.1093/nar/29.3.767.PubMed CentralView ArticlePubMedGoogle Scholar
- Lu KP, Liou YC, Zhou XZ: Pinning down proline-directed phosphorylation signaling. Trends Cell Biol. 2002, 12: 164-172. 10.1016/S0962-8924(02)02253-5.View ArticlePubMedGoogle Scholar
- Uchida T, Takamiya M, Takahashi M, Miyashita H, Ikeda H, Terada T, Matsuo Y, Shirouzu M, Yokoyama S, Fujimori F, Hunter T: Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem Biol. 2003, 10: 15-24. 10.1016/S1074-5521(02)00310-1.View ArticlePubMedGoogle Scholar
- Thibodeau A, Duchaine J, Simard JL, Vincent M: Localization of molecules with restricted patterns of expression in morphogenesis: an immunohistochemical approach. Histochem J. 1989, 21: 348-356.View ArticlePubMedGoogle Scholar
- Kramer A, Haars R, Kabisch R, Will H, Bautz FA, Bautz EK: Monoclonal antibody directed against RNA polymerase II of Drosophila melanogaster. Mol Gen Genet. 1980, 180: 193-199.View ArticlePubMedGoogle Scholar
- Wada T, Takagi T, Yamaguchi Y, Watanabe D, Handa H: Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. Embo J. 1998, 17: 7395-7403. 10.1093/emboj/17.24.7395.PubMed CentralView ArticlePubMedGoogle Scholar
- Kimura K, Nozaki N, Saijo M, Kikuchi A, Ui M, Enomoto T: Identification of the nature of modification that causes the shift of DNA topoisomerase II beta to apparent higher molecular weight forms in the M phase. J Biol Chem. 1994, 269: 24523-24526.PubMedGoogle Scholar
- Williams KR, Stone KL: Enzymatic cleavage and HPLC peptide mapping of proteins. Mol Biotechnol. 1997, 8: 155-167.View ArticlePubMedGoogle Scholar
- Peng J, Marshall NF, Price DH: Identification of a cyclin subunit required for the function of Drosophila P-TEFb. J Biol Chem. 1998, 273: 13855-13860. 10.1074/jbc.273.22.13855.View ArticlePubMedGoogle Scholar
- Cho EJ, Kobor MS, Kim M, Greenblatt J, Buratowski S: Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain. Genes Dev. 2001, 15: 3319-3329. 10.1101/gad.935901.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.